Video Stephen Hawking, take heart: Revalesio’s ALS drug gets regulatory boost from FDA by Alan Boyle on September 21, 2017September 21, 2017 at 3:29 pm Revalesio, a biomedical company headquartered in Tacoma, Wash., says it’s been cleared to benefit from federal incentives for the development of a drug that could help treat a neurodegenerative disease… Read More